Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Sci Rep ; 11(1): 12903, 2021 06 18.
Article in English | MEDLINE | ID: mdl-34145342

ABSTRACT

Abdominal aortic aneurysm (AAA) is a complex disease which is incompletely accounted for. Basement membrane (BM) Collagen IV (COL4A1/A2) is abundant in the artery wall, and several lines of evidence indicate a protective role of baseline COL4A1/A2 in AAA development. Using Col4a1/a2 hemizygous knockout mice (Col4a1/a2+/-, 129Svj background) we show that partial Col4a1/a2 deficiency augmented AAA formation. Although unchallenged aortas were morphometrically and biomechanically unaffected by genotype, explorative proteomic analyses of aortas revealed a clear reduction in BM components and contractile vascular smooth muscle cell (VSMC) proteins, suggesting a central effect of the BM in maintaining VSMCs in the contractile phenotype. These findings were translated to human arteries by showing that COL4A1/A2 correlated to BM proteins and VSMC markers in non-lesioned internal mammary arteries obtained from coronary artery bypass procedures. Moreover, in human AAA tissue, MYH11 (VSMC marker) was depleted in areas of reduced COL4 as assessed by immunohistochemistry. Finally, circulating COL4A1 degradation fragments correlated with AAA progression in the largest Danish AAA cohort, suggesting COL4A1/A2 proteolysis to be an important feature of AAA formation. In sum, we identify COL4A1/A2 as a critical regulator of VSMC phenotype and a protective factor in AAA formation.


Subject(s)
Aortic Aneurysm, Abdominal/etiology , Basement Membrane/metabolism , Collagen Type IV/deficiency , Genetic Predisposition to Disease , Alleles , Animals , Aortic Aneurysm, Abdominal/metabolism , Aortic Aneurysm, Abdominal/pathology , Biomarkers , Biopsy , Collagen Type IV/genetics , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Genetic Association Studies , Genotype , Immunohistochemistry , Male , Mice , Mice, Knockout , Muscle, Smooth, Vascular/metabolism , Myocytes, Smooth Muscle/metabolism , Proteolysis , Proteome , Proteomics/methods
2.
Clin Oral Investig ; 23(7): 3139, 2019 07.
Article in English | MEDLINE | ID: mdl-30915556

ABSTRACT

There is a mistake in the original published version of this article. The word 'Streptococcus' in the article title should have been 'Staphylococcus'.

3.
Clin Oral Investig ; 22(7): 2663-2668, 2018 09.
Article in English | MEDLINE | ID: mdl-29948278

ABSTRACT

OBJECTIVE: Staphylococcus epidermidis, as a primary colonizer, is strongly associated with infections of (dental) implants (i.e., peri-implantitis), but little is known about the surface proteome of this bacterium. For the identification of bacterial adhesins, this study investigated the surface proteome of S. epidermidis adhering directly to titanium implant substrata. MATERIALS AND METHODS: S. epidermidis strain ATTC 35984 was cultured either planktonically or on titanium implant specimens. The surface proteomes were isolated by mutanolysin digestion, and proteins were separated by 2D gel electrophoreses to reveal highly expressed proteins only. Protein spots were visualized by silver staining and proteins were identified by mass spectrometry. RESULTS: Surface proteome analyses of S. epidermidis on titanium identified six expressed proteins. Three proteins were highly expressed on the titanium implants including accumulation-associated protein Q8CQD9. These specific proteins could be potential pathogenicity factors of bacteria in peri-implant biofilms. CONCLUSION: For the first time, our study identified S. epidermidis surface proteins, which are expressed after adhesion to titanium implant materials. CLINICAL RELEVANCE: Our study reveals possible candidates for a newly protein-based vaccine against peri-implantitis.


Subject(s)
Dental Implants/microbiology , Dental Materials/chemistry , Membrane Proteins/metabolism , Staphylococcus epidermidis/metabolism , Titanium/chemistry , Bacterial Adhesion , Electrophoresis, Polyacrylamide Gel , Proteomics/methods , Staphylococcus epidermidis/pathogenicity , Surface Properties
4.
Mol Cell Biochem ; 428(1-2): 79-86, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28116542

ABSTRACT

Dental follicle stem cells (DFCs) are precursor cells of alveolar osteoblasts, and previous studies have shown that the growth factor bone morphogenetic protein (BMP)2 induces the osteogenic differentiation of DFCs. However, the molecular mechanism down-stream of the induction of the osteogenic differentiation by BMP2 remains elusive. We investigated therefore the phosphoproteome of DFCs after the induction of the osteogenic differentiation with BMP2. In this study, phosphoproteins of the hedgehog "off" state were differentially expressed. Further analyses revealed that BMP2 induced the expression of repressors of the hedgehog-signaling pathway such as Patched 1 (PTCH1), Suppressor of Fused (SUFU), and Parathyroid Hormone-Related Peptide (PTHrP). Previous studies suggested that hedgehog proteins induce the osteogenic differentiation of mesenchymal stem cells via a paracrine pathway. Indian hedgehog (IHH) induced the expression of the osteogenic transcription factor RUNX2. However, a supplementation of the BMP2-based osteogenic differentiation medium with IHH did not induce the expression of RUNX2. Moreover, IHH inhibited slightly the ALP activity and the mineralization of osteogenic-differentiated DFCs. In conclusion, our results suggest that BMP2 inhibits the hedgehog signaling after the induction of the osteogenic differentiation in DFCs.


Subject(s)
Bone Morphogenetic Protein 2/pharmacology , Dental Sac/cytology , Hedgehog Proteins/metabolism , Stem Cells/cytology , Cell Differentiation/drug effects , Cells, Cultured , Dental Sac/metabolism , Gene Expression Regulation , Humans , Osteogenesis/drug effects , Phosphoproteins/metabolism , Phosphorylation , Proteomics/methods , Signal Transduction/drug effects , Stem Cells/metabolism
5.
J Inherit Metab Dis ; 36(6): 1015-24, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23494656

ABSTRACT

BACKGROUND: Alpha-mannosidosis (OMIM 248500) is a rare lysosomal storage disease (LSD) caused by alpha-mannosidase deficiency. Manifestations include intellectual disabilities, facial characteristics and hearing impairment. A recombinant human alpha-mannosidase (rhLAMAN) has been developed for weekly intravenous enzyme replacement therapy (ERT). We present the preliminary data after 12 months of treatment. METHODS: This is a phase I-II study to evaluate safety and efficacy of rhLAMAN. Ten patients (7-17 y) were treated. We investigated efficacy by testing motor function (6-minutes-Walk-Test (6-MWT), 3-min-Stair-Climb-Test (3-MSCT), The Bruininks-Oseretsky Test of Motor Proficiency (BOT2), cognitive function (Leiter-R), oligosaccharides in serum, urine and CSF and Tau- and GFA-protein in CSF. RESULTS: Oligosaccharides: S-, U- and CSF-oligosaccharides decreased 88.6% (CI -92.0 -85.2, p < 0.001), 54.1% (CI -69.5- -38.7, p < 0,001), and 25.7% (CI -44.3- -7.1, p < 0.05), respectively. Biomarkers: CSF-Tau- and GFA-protein decreased 15%, p < 0.009) and 32.5, p < 0.001 respectively. Motor function: Improvements in 3MSCT (31 steps (CI 6.8-40.5, p < 0.01) and in 6MWT (60.4 m (CI -8.9 -51.1, NS) were achieved. Cognitive function: Improvement in the total Equivalence Age of 4 months (0.34) was achieved in the Leiter R test (CI -0.2-0.8, NS). CONCLUSIONS: These data suggest that rhLAMAN may be an encouraging new treatment for patients with alpha-mannosidosis.The study is designed to continue for a total of 18 months. Longer-term follow-up of patients in this study and the future placebo-controlled phase 3 trial are needed to provide greater support for the findings in this study.


Subject(s)
Enzyme Replacement Therapy , alpha-Mannosidase/administration & dosage , alpha-Mannosidosis/drug therapy , Adolescent , Child , Cognition/drug effects , Dose-Response Relationship, Drug , Enzyme Replacement Therapy/adverse effects , Enzyme Replacement Therapy/methods , Exercise Test , Follow-Up Studies , Humans , Psychomotor Performance/drug effects , Recombinant Proteins/administration & dosage , Recombinant Proteins/adverse effects , Recombinant Proteins/immunology , Recombinant Proteins/pharmacokinetics , Treatment Outcome , alpha-Mannosidase/adverse effects , alpha-Mannosidase/immunology , alpha-Mannosidase/pharmacokinetics
6.
J Appl Microbiol ; 96(5): 1185-93, 2004.
Article in English | MEDLINE | ID: mdl-15078537

ABSTRACT

AIMS: Staphylococcus xylosus is an important starter culture in the production of flavours from the branched-chain amino acids leucine, valine and isoleucine in fermented meat products. The sensorially most important flavour compounds are the branched-chain aldehydes and acids derived from the corresponding amino acids and this paper intends to perspectivate these flavour compounds in the context of leucine metabolism. METHODS AND RESULTS: GC and GC/MS analysis combined with stable isotope labelling was used to study leucine catabolism. This amino acid together with valine and isoleucine was used as precursors for the production of branched-chain fatty acids for cell membrane biosynthesis during growth. A 83.3% of the cellular fatty acids were branched. The dominating fatty acid was anteiso-C(15:0) that constituted 55% of the fatty acids. A pyridoxal 5'-phosphate and alpha-ketoacid dependent reaction catalysed the deamination of leucine, valine and isoleucine into their corresponding alpha-ketoacids. As alpha-amino group acceptor alpha-keto-beta-methylvaleric acid and alpha-ketoisovaleric acid was much more efficient than alpha-ketoglutarate. The sensorially and metabolic key intermediate on the pathway to the branched-chain fatty acids, 3-methylbutanoic acid was produced from leucine at the onset of the stationary growth phase and then, when the growth medium became scarce in leucine, from the oxidation of glucose via pyruvate. CONCLUSIONS: This paper demonstrates that the sensorially important branched-chain aldehydes and acids are important intermediates on the metabolic route leading to branched-chain fatty acids for cell membrane biosynthesis. SIGNIFICANCE AND IMPACT OF THE STUDY: The metabolic information obtained is extremely important in connection with a future biotechnological design of starter cultures for production of fermented meat.


Subject(s)
Fatty Acids/biosynthesis , Flavoring Agents/metabolism , Food Microbiology , Leucine/metabolism , Staphylococcus/metabolism , Cell Membrane/metabolism , Chromatography/methods , Culture Media , Glucose/metabolism , Hemiterpenes , Isoleucine/metabolism , Keto Acids/metabolism , Meat Products/microbiology , Oxidation-Reduction , Pentanoic Acids/metabolism , Pyruvic Acid/metabolism , Valine/metabolism
7.
Biotechnol Bioeng ; 51(1): 23-32, 1996 Jul 05.
Article in English | MEDLINE | ID: mdl-18627084

ABSTRACT

Membrane inlet mass spectrometry has been used for the characterization of halogenated organic compounds produced by the fungus Bjerkandera adusta. Using this technique we obtained electron impact-, chemical ionization-, electron capture negative chemical ionization-mass spectra and tandem mass spectra directly from the growth medium. Through this direct analysis of the samples we identified novel bioconversion products and confirmed recently published data on the production of both chlorinated and brominated methoxybenzaldehyde metabolites. Growth profiles of the culture grown on a defined medium showed that the production of secondary metabolites starts after approximately 6 days and reaches maximal concentrations of 25-250 muM after 15-20 days. Although delayed, the production of secondary metabolites paralleled a depletion of glucose from the medium and stopped shortly after all glucose had been consumed. Experiments in which fluoro- and bromo-labeled 4-methoxybenzaldehydes were added to the medium at day 8 showed biotransformation of these compounds into chloro-3-fluoro-4-methoxy-benzaldehyde and chloro-3-bromo-4-methoxybenzaldehyde, respectively. No dichlorinated products were observed, suggesting that halogenation takes place only at the meta position on the 4-methoxybenzaldehydes. These experiments are the first to bring direct evidence of a halogenation mechanism, where the enzymatic attack takes place directly on the 4-methoxybenzaldehyde intermediates. (c) John Wiley & Sons, Inc.

8.
Biochemistry ; 24(24): 6894-903, 1985 Nov 19.
Article in English | MEDLINE | ID: mdl-3907704

ABSTRACT

The serine residue in the active center of atropinesterase (AtrE), alpha-chymotrypsin (Chymo), and subtilisin A (Sub) and in alpha-chymotrypsinogen (Chymogen) was labeled with a diisopropylphosphoryl (DP) group. The labeled proteins were studied in buffered aqueous solution under various native and denaturing conditions with 31P NMR before and after being subjected to "ageing", a process leading to conversion of the DP group into a monoisopropylphosphoryl (MP) group. Besides, the model compounds Gly-Ser(DP), Gly-Glu-Ser(DP)-Gly-OEt, and diisopropyl hydrogen phosphate were investigated under similar conditions and in other solvents with different hydrogen-bonding capacity. Mass spectrometry was used to analyze products resulting from ageing in the presence of H2(18)O. The 31P chemical shift of the DP proteins increases according to a simple titration curve upon lowering the pH from 9.0 to 5.0. This is ascribed to protonation of a particular histidine residue in the active center that interacts with a nearby isopropoxy group by hydrogen bonding with the ester oxygen. In DP-AtrE, hydrogen bonding at the phosphoryl oxygen dominates the interaction between substituent and protein; in the other DP proteins, nonbonding interactions become more dominant in the order Chymogen less than Chymo less than Sub. DP-AtrE, DP-Chymo, and DP-Sub age according to first-order kinetics. The pH dependence of the reaction rate constant ka indicates that ageing is catalyzed by the protonated histidine, which is responsible for the increase in chemical shift. The direct interaction between the phosphoryl group and the histidine is lost upon ageing whereas there is an increase in the nonbonding interaction of the remaining isopropyl group with the protein in the order Chymo less than Sub less than AtrE. The maximum value of ka when the histidine is fully protonated (kam) increases in the same order. Ageing of the DP enzymes occurs exclusively by C-O fission, yielding 2-propanol and propene. Since the amount of 2-propanol decreased and that of propene increased in the order Chymo to Sub to AtrE, the increase in kam has been interpreted as a shift in character of ageing from mainly SN2 for Chymo to considerably SN1 for AtrE and Sub. This has been attributed to preferential stabilization of the SN1 transition state by an interplay of hydrogen-bonding and nonbonding interactions between the phosphoryl group and the protein.(ABSTRACT TRUNCATED AT 400 WORDS)


Subject(s)
Carboxylic Ester Hydrolases/metabolism , Endopeptidases/metabolism , Animals , Cattle , Chymotrypsin/metabolism , Chymotrypsinogen/metabolism , Hydrogen-Ion Concentration , Kinetics , Magnetic Resonance Spectroscopy , Mass Spectrometry , Pancreas/enzymology , Phosphorylation , Pseudomonas/enzymology , Serine Endopeptidases , Subtilisins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...